![Dani Paul Bolognesi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dani Paul Bolognesi
Directeur Général chez
B3 Bio, Inc.
Profil
Dani Paul Bolognesi is the founder of B3 Bio, Inc., founded in 2007, serving as Chairman & Chief Executive Officer.
Current jobs include Chief Executive Officer at Enci Therapeutics, Inc., and Director at Senex Biotechnology, Inc. and Istari Oncology, Inc. Former jobs include Director at Transgeneron Therapeutics, Inc., Director at Duke University, Director at InnAVasc Medical, Inc., and Chief Executive & Scientific Officer at Trimeris, Inc. from 1993 to 2004.
Education includes a doctorate from Duke University.
Postes actifs de Dani Paul Bolognesi
| Sociétés | Poste | Début |
|---|---|---|
B3 Bio, Inc.
 B3 Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Develops ribonucleic acid oligonucleotide based drugs | Directeur Général | 10/09/2009 |
Istari Oncology, Inc.
 Istari Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology that focused on novel immuno-oncology and immunotherapy products | Directeur/Membre du Conseil | 01/01/2016 |
Senex Biotechnology, Inc.
 Senex Biotechnology, Inc. BiotechnologyHealth Technology Develops oncology drugs | Directeur/Membre du Conseil | - |
Anciens postes connus de Dani Paul Bolognesi
| Sociétés | Poste | Fin |
|---|---|---|
Trimeris, Inc.
 Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for viral diseases | President | - |
InnAVasc Medical, Inc.
 InnAVasc Medical, Inc. Medical SpecialtiesHealth Technology Operates as medical devices company that designs and develops products for vascular access for hemodialysis | Directeur/Membre du Conseil | - |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Membre du Conseil | - |
Transgeneron Therapeutics, Inc.
 Transgeneron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic medicine that promotes tissue regeneration | Directeur/Membre du Conseil | - |
Formation de Dani Paul Bolognesi
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
28
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Trimeris, Inc.
Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for viral diseases | Health Technology |
Transgeneron Therapeutics, Inc.
Transgeneron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic medicine that promotes tissue regeneration | Health Technology |
Senex Biotechnology, Inc.
Senex Biotechnology, Inc. BiotechnologyHealth Technology Develops oncology drugs | Health Technology |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
B3 Bio, Inc.
B3 Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Develops ribonucleic acid oligonucleotide based drugs | Commercial Services |
InnAVasc Medical, Inc.
InnAVasc Medical, Inc. Medical SpecialtiesHealth Technology Operates as medical devices company that designs and develops products for vascular access for hemodialysis | Health Technology |
Istari Oncology, Inc.
Istari Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology that focused on novel immuno-oncology and immunotherapy products | Health Technology |
